|
Report No. : |
353792 |
|
Report Date : |
11.12.2015 |
IDENTIFICATION DETAILS
|
Name : |
MYLAN IRELAND LTD |
|
|
|
|
Registered Office : |
Newenham Court Northern Cross Malahide Road Dublin
17 |
|
|
|
|
Country : |
Ireland |
|
|
|
|
Date of Incorporation : |
November 2011 |
|
|
|
|
Legal Form : |
Foreign Business not Registered with RCS (business
and companies Register) |
|
|
|
|
Line of Business : |
Wholesale trade (trade intercompany)
pharmaceuticals. |
|
|
|
|
No. of Employee : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
C |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
Status : |
Undetermined |
|
|
|
|
Payment Behaviour : |
-- |
|
|
|
|
Litigation : |
-- |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Ireland |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
IRELAND ECONOMIC
OVERVIEW
Ireland is a small, modern, trade-dependent economy. Ireland was among the initial group of 12 EU nations that began circulating the euro on 1 January 2002. GDP growth averaged 6% in 1995-2007, but economic activity dropped sharply during the world financial crisis and the subsequent collapse of its domestic property market and construction industry. Faced with sharply reduced revenues and a burgeoning budget deficit from efforts to stabilize its fragile banking sector, the Irish Government introduced the first in a series of draconian budgets in 2009. These measures were not sufficient to stabilize Ireland’s public finances. In 2010, the budget deficit reached 32.4% of GDP - the world's largest deficit, as a percentage of GDP. In late 2010, the former COWEN government agreed to a $92 billion loan package from the EU and IMF to help Dublin recapitalize Ireland’s banking sector and avoid defaulting on its sovereign debt. In March 2011, the KENNY government intensified austerity measures to meet the deficit targets under Ireland's EU-IMF bailout program. In late 2013, Ireland formally exited its EU-IMF bailout program, benefiting from its strict adherence to deficit-reduction targets and success in refinancing a large amount of banking-related debt. In 2014, the economy rapidly picked up and GDP grew by 3.6%. The recovering economy assisted lowering the deficit to 4.2% of GDP. In late 2014, the government introduced a fiscally neutral budget, marking the end of the austerity program. In the wake of the collapse of the construction sector and the downturn in consumer spending and business investment, the export sector, dominated by foreign multinationals, has become an even more important component of Ireland's economy. Ireland’s low corporation tax of 12.5% has been central to encouraging business investment. Loose tax residency requirements made Ireland a common destination for international firms seeking to avoid taxation. Amid growing international pressure the government announced it would phase in more stringent tax laws, effectively closing a loophole.
|
Source
: CIA |
|
Name |
MYLAN IRELAND LTD |
|
|
|
Acronym |
- |
|
|
|
Trade name |
- |
|
|
|
Status |
Economically active |
|
|
|
Postal Address |
MYLAN
IRELAND LTD NEWENHAM
COURT NORTHERN CROSSMALAHIDE ROAD DUBLIN 17
IRLANDE |
|
|
|
Share Capital |
- |
|
|
|
Telephone |
- |
|
|
|
Activity (APE) |
Wholesale trade (tradeintercompany )
pharmaceuticals (4646Z) |
RCS Registration |
|
|
Formation Date |
11/2011 |
EUR VAT Number |
- |
|
Deregistration Date |
- |
Last account Date |
- |
|
Court Registry Number |
- |
Incorporiation Date |
- |
|
Registration Court |
- |
Fax |
- |
|
Nationality |
- |
|
|
|
|
|
Legal form |
Foreign Business not Registered
with RCS |
|
|
|
Currency |
- |
|
|
|
|
|
There are no trends available for a company
No identified director for this company
|
Judgment |
No judgement |
|
Preferential Right |
This company is not under
monitoring |
|
Type of Establishment |
Head Office |
Production Role |
- |
|
APE/NAF Code |
4646Z |
Activity |
Wholesale ( business to business ) products pharmaceutical |
|
Formation Date |
11/2011 |
Reason for Formation |
Formation |
|
Closure Date |
- |
Reason for Closure |
- |
|
Reactivation Date |
- |
Seasonality |
- |
|
Activity Nature |
- |
Activity Location |
- |
|
Trading Address |
NEWENHAM COURT |
Department |
|
|
|
NORTHERN CROSS |
|
- |
|
|
MALAHIDE ROAD DUBLIN 17 |
|
|
|
Location Surface |
- |
District |
- |
|
City |
MALAHIDE ROAD DUBLIN 17 |
Status |
Economically active |
|
Business Pages FT® |
- |
Region |
Etranger |
|
|
|
Area |
- |
|
|
|
Size of Urban Area |
- |
|
Regionality |
- |
|
Mono-activity status |
- |
|
Branches |
0 branch entities in this company |
|
Company
Name |
Company
Type |
APE/NAF
Code |
Activity |
City |
Post
Code |
|
MYLAN IRELAND LTD |
Head Office |
4646Z |
Wholesale (business to business) pharmaceuticals |
MALAHIDE ROAD DUBLIN 17 |
|
|
Workforce
at address |
0 employee |
Company
workforce |
0 employee |
The comments are ordered
according to the class of risk.
Companies are compared with regard to
other companies of the same type.
Thus a positive comment for one category
can be negative for another or can
change depending on its value. This
is a purely statistical decision.
|
Activity (APE) |
Wholesale ( business to business ) pharmaceuticals
(4646Z) |
|
Industry average credit rating |
43 |
|
Industry average credit limit |
90,654 |
No judgment information for
the company
|
Status of collection |
This company is not under
monitoring |
No group information available
for the company
No Shareholders available for
this company
No Linkages information available
for the company.
No identified director for
this company
No data about previous
directors is available for this company
|
Date |
Description |
|
01/07/2015 |
Economically active |
No Gazette Publications
No Company Events History
No Establishment Events History
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.66.79 |
|
|
1 |
Rs.101.37 |
|
Euro |
1 |
Rs.73.46 |
|
EUR |
1 |
Rs.73.22 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
HNA |
|
|
|
|
Report Prepared
by : |
ANK |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.